Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome

Prenatal Diagnosis

Volumn 22, Issue 8, 2002, Pages 730-735

  Lam, Yung Hang ^a,f   Lee, Chin Peng ^a   Sin, Sai Yuen ^b   Tang, Rebecca ^c   Wong, Hong Soo ^d   Wong, Sai Fun ^e   Fong, Danial Yee Tak ^a   Tang, Mary Hoi Yin ^a   Woo, Hennie Hai Nin ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

^c PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

^e TUEN MUN HOSPITAL   (Hong Kong)

^f TSAN YUK HOSPITAL   (Hong Kong)

Author keywords

Down syndrome; Nuchal translucency; Screening; Serum screening; Ultrasound

Indexed keywords

ADULT; ARTICLE; CHORION VILLUS SAMPLING; COMPARATIVE STUDY; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC RISK; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; AMNIOCENTESIS; BLOOD; ECHOGRAPHY; FETUS HYDROPS; GESTATIONAL AGE; HIGH RISK PREGNANCY; LABORATORY DIAGNOSIS; NECK; PRENATAL DEVELOPMENT; RISK FACTOR; ROC CURVE;

ALPHA-FETOPROTEINS; AMNIOCENTESIS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; COMPARATIVE STUDY; DOWN SYNDROME; FALSE POSITIVE REACTIONS; GESTATIONAL AGE; HYDROPS FETALIS; MATERNAL AGE 35 AND OVER; NECK; PRENATAL DIAGNOSIS; RISK FACTORS; ROC CURVE; SUPPORT, NON-U.S. GOV'T; ULTRASONOGRAPHY, PRENATAL; MATERNAL AGE; PREGNANCY, HIGH-RISK;

HYDROPS;

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN;

EID: 0036023291     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.382     Document Type: Article

References (26)

1. Chorion villus sampling versus amniocentesis for prenatal diagnosis
2. Down syndrome screening. ACOG Committee Opinion: Committee on Obstetric Practice, No. 141, August 1994 (replaces No. 76, December 1989)
3. Antenatal screening for aneuploidy
4. Biochemical screening for Down syndrome
5. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level
6. Image magnification does not contribute to the repeatability of caliper placement in measuring nuchal translucency thickness
7. Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women
8. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong
9. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation
10. Acceptability of serum screening as an alternative to cytogenetic diagnosis of Down syndrome among women 35 years or older in Hong Kong
11. First-trimester screening for aneuploidy: Research or standard of care?
12. The psychological effects of false-positive results in prenatal screening for fetal abnormality: A prospective study
13. Fetal loss in Down syndrome pregnancies
14. Refinements in managing maternal weight adjustment for interpreting prenatal screening results
15. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
16. Maternal serum screening for Down syndrome in the United States: A 1995 survey
17. Model-based screening by risk with application to Down's syndrome
18. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14weeks of gestation
19. Maternal age- and gestation-specific risk for trisomy 21
20. Prenatal screening for Down's syndrome using inhibin-A as a serum marker
21. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters
22. The effect of fetal neck position on nuchal translucency measurement
23. Learning in medicine; chorionic villus sampling
24. Assessment of first-trimester nuchal translucency by daily reference intervals